Paul Scott-Murphy VP of Product Management WANdisco, Jean-Pierre Dijcks, PM, Oracle, Nick Collins, Director, Accenture
Back by popular demand for our EMEA audience. Register now to learn more about how to meet enterprise SLAs with Oracle Maximum Availability Architecture.
During this webinar you will learn how to:
- Deploy Oracle BDA and BDCS in environments running any mix of HCFS compatible distributions with a path for full cluster migration with no downtime and no data loss
- Replicate selected data among multiple big data systems and verify that they remain consistent regardless of where they are ingested or changed
- Replicate data at any geographic distance with significantly low RPO and RTO
Complete data transfer in approximately half the time of DistCp regardless of the load imposed on the cluster
- Overcome the limitations of traditional approaches that leverage DistCp or dual-ingest methods
As VP of Product Management at WANdisco, Paul Scott-Murphy has overall responsibility for the definition and management of WANdisco's product strategy, the delivery of product to market and its success. This includes direction of the product management team, product strategy, requirements definitions, feature management and prioritization, roadmaps, coordination of product releases with customer and partner requirements, user testing and feedback.
Jean-Pierre Dijcks, Master Product Manager, Oracle. Highly experienced product manager with 15 years of experience in enterprise software and enterprise data. Currently responsible for all product management aspects (technology, GTM, Enablement etc.) of Oracle Big Data Appliance and Big Data Cloud Service at Oracle.
Nick Collins, Big Data Practice Director, Accenture Enkitec Group. Nick Collins is the Big Data Practice Director for the Accenture Enkitec Group. He has extensive experience with Oracle Big Data Appliance and Oracle Exadata, and a strong background in data warehousing and analytics. He has worked with Oracle technology for over ten years, and possesses significant industry depth in healthcare and genomics.